Neuroinflammation in Parkinson disease
Parkinson disease (PD) is a motor system disorder, which is characterized by tremor, rigidity, slowed movements, and impaired balance and coordination and results from the loss of dopamine-producing cells in the brain. The nigrostriatal pathway - a neural pathway connecting the substantia nigra with the striatum - is one of four major dopamine signaling pathways in the brain and is prominently involved in controlling movement. In PD, the nigrostriatal pathway as well as dopaminergic and nondopaminergic neurons are compromised, and this is accompanied by inflammatory changes in microglia (the innate immune cells of the central nervous system) and infiltration of T lymphocytes (cells of the adaptive immune system). It has long been thought that microglial and T cell infiltration are not primary events in the pathogenesis of neurodegeneration but are instead responses to neuronal injury. However, recent studies (discussed below) support an alternative point of view and provide compelling evidence that both activated microglia and T lymphocytes make a significant contribution to neurodegeneration, at the very least by amplifying and exacerbating an ongoing inflammatory process and by triggering extensive neuronal degeneration to develop from a small population of stressed dopaminergic neurons. 
α-Synuclein as a mediator of microglial activation
The question of what could activate microglia and in turn aggravate neuronal injury has focused attention on the protein α-synuclein (α-Syn), which is expressed predominantly in neurons and is particularly enriched at presynaptic terminals. α-Syn accumulates in mutant forms (7) or as overexpressed wildtype protein (8) in familial PD and in nitrated and oxidized forms in cytosolic aggregates in PD patients (9) . Transgenic expression of human α-Syn in mice renders dopaminergic neurons more vulnerable to LPS-induced inflammation, which in turn leads to accumulation of insoluble α-Syn aggregates in nigral neurons (10) . In dopaminergic neuronal cultures, dopaminergic neuron cytotoxicity is dependent on the presence of α-Syn and is attenuated in the presence of inhibitors of NO and superoxide released from microglia (10). Thus, altered forms of α-Syn released from stressed neurons appear to participate in a self-propagating cycle, in which microglia are activated, enhancing the release of free radicals and proinflammatory cytokines and further amplifying dopaminergic neurodegeneration. Previous studies have shown that levels of IFN-γ are significantly elevated in PD patients as well as in the MPTP-mediated mouse model of PD (12) . In Ifng -/-mice, MPTP-induced loss of substantia nigra pars compacta neurons was attenuated as was microglial activation (12) . The importance of Ifn-γ would suggest the involvement of CD4 + Th1 cells, which can secrete Ifn-γ and
T cells mediate cytotoxicity in the MPTP-induced mouse model of PD

Figure 1
Potential role of T cells in modulating micro gliamediated neurotoxicity. On the left, the presence of Th1 and Th17 cells upregulates (thick lines) the production and release of free radicals from microglia, including NO, superoxide (O2 -), and hydrogen peroxide (H2O2) as well as proinflammatory cytokines such as TNFα and IL1β, and downregulates (thin lines) the release of neurotrophic fac tors such as IGF1. The result is enhanced neuronal injury, which may trigger the release of increased levels of nitrated/oxidized αSyn and enhance microgliamediated neurotoxic ity. Tregs can suppress the proinflammatory effects of Th17 cells. On the right, Th2 cells release IL4, upregulating the release from microglia of neuroprotective IGF1, downreg ulating release of free radicals, and resulting in enhanced neuronal protection.
activate microglia (13) . However, in the current study reported by Brochard et al. (11) , the fact that the effect on MPTP-induced neurodegeneration was the same irrespective of whether spleen cells were passively transferred from wild-type or Ifng -/-mice (11) suggests that Ifn-γ may not be required for T cell-mediated dopaminergic cell death. Thus Th1 cells, which secrete Ifn-γ, may not be the relevant subpopulation involved in the MPTP-mediated T cell toxicity observed. The demonstration that expression of a functional FasL was required for the CD4 + Th cell-mediated dopaminergic cell death supports the involvement of CD4 + FasL + T cell populations, which could activate microglia to secrete proinflammatory factors (14) . The recently described IL-17-secreting Th17 lymphocytes represent another proinflammatory T cell that could mediate CD4 + T cell-induced cytotoxicity. The main function of IL-17-secreting T cells is to mediate inflammation, by stimulating production of inflammatory cytokines such as TNF-α, IL-1β, and IL-6 (15) . Clearly, the identity of the T cells responsible for the enhanced dopaminergic cytotoxicity cannot be definitively determined until this issue is addressed by passive transfer of specific subpopulations of CD4 + T cells. It is of interest that nitrated α-Syn may participate in the T cell-mediated cytotoxicity, since transfer of T cells from mice immunized with nitrotyrosine-modified α-Syn led to a robust neuroinflammatory response, with accelerated dopaminergic cell loss (16) . Collectively, the data suggest that CD4 + T cells mediate cytotoxicity, by activating microglia to release free radicals and proinflammatory cytokines and induce dopaminergic neurodegeneration. However, a direct toxic effect of CD4 + T cells on substantia nigra dopaminergic neurons cannot be excluded.
Neuroinflammation can be neuroprotective as well as cytotoxic
Marked microglial activation and lymphocytic infiltration are also present in patients with the neurodegenerative disease amyotrophic lateral sclerosis (ALS) as well as in transgenic mice overexpressing mutant Cu-Zn superoxide dismutase 1 (mSOD1), an animal model of familial ALS (17) . Surprisingly, T cells were reported to be neuroprotective in this model, rather than cytotoxic as currently reported in the MPTP-induced murine models of PD (11) (Figure 1 ). When mSOD1 mice were bred with Rag2 -/-mice lacking functional T cells or with Cd4 -/-mice lacking CD4 + T cells, motor neuron disease was accelerated, accompanied by increased mRNA levels of proinflammatory cytokines and NADPH oxidase 2 (NOX2), which is responsible for generating superoxide (18) . Levels of trophic factors and glial glutamate transporters were also decreased. Bone marrow transplants reconstituted mice with T cells, prolonged survival, and suppressed cytotoxicity in conjunction with restoring expression of neuroprotective factors and lessening the expression of NOX2. Thus, CD4 + T cells significantly influence the neurodegenerative process in both the MPTP-induced murine model of PD and a transgenic mouse model of familial ALS, mediating cytotoxicity in the former and neuroprotection in the latter.
Conclusion
The development of immunotherapeutic approaches to the treatment of PD will depend on determining which subpopulations of CD4 + T cells are responsible for cytotoxicity and which of these may enhance neuroprotection. With the compelling evidence now provided by Brochard and colleagues (11) , that CD4 + T cells mediate cytotoxicity in the MPTP-induced mouse model of PD, Th1 and Th17 cells become potential targets in efforts to minimize the hostile neuronal microenvironment. IL-12 enhances expression of the transcription factors STAT4 and T-bet, which regulate lineage commitment and development of CD4 + Th cells from naive T cells. TGF-β, in addition to IL-6 or IL-21, enhances expression of the transcription factor RORγt and promotes development of Th17 from naive T cells, the expansion of which is enhanced by IL-1 and IL-23 (19) . Suppressing these differentiating signals as well as the Th1 and/or Th17 cells themselves has now become a potentially meaningful approach to immunotherapy for PD. An alternative approach might focus on Tregs, which appear capable of regulating immune responses mediated by other T cell subtypes, including Th17 cells. Therefore, increasing numbers of Tregs in order to suppress proinflammatory T cells might also foster a more neuroprotective environment. Most significantly, these and other immune-based strategies now have a cogent rationale, given the demonstration that T cells themselves are orchestrating cytotoxic events in the MPTP-induced mouse model of PD (11) and possibly in human PD itself.
